Opportunity
Simpler Grants.gov #PA-27-100
Forecasted SBIR Grant Opportunity for Biomedical and Public Health R&D (NIH, CDC, FDA)
Buyer
National Institutes of Health
Posted
April 28, 2026
Respond By
September 05, 2026
Identifier
PA-27-100
NAICS
541715, 541714, 541713
This forecasted opportunity invites US small businesses to apply for Small Business Innovation Research (SBIR) grants supporting the R&D missions of the National Institutes of Health (NIH), Centers for Disease Control (CDC), and Food and Drug Administration (FDA). - Government Buyers: - National Institutes of Health (NIH) - Centers for Disease Control (CDC) - Food and Drug Administration (FDA) - Eligible Applicants: - US small business concerns (SBCs) with research and technological expertise - Products/Services Requested: - No specific products or services listed - Grant applications for research and development projects in biomedical, health, and public health fields - Activity codes: R43/R44 (SBIR) - Unique/Notable Requirements: - Eligibility limited to US small businesses as defined by the SBA - Encouragement of collaborative investigations - Wide range of research topics covered, including biomedical research, disease prevention, cancer research, and environmental health - No OEMs or vendors specified, as this is a grant opportunity for research proposals, not a procurement of specific products or services.
Description
The National Institutes of Health (NIH), along with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), intends to publish a Notice of Funding Opportunity (NOFO) inviting eligible United States small business concerns to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Direct to Phase II (NIH Only), and Fast-Track (NIH only) grant applications. This NOFO will utilize the R43/R44 activity code. The opportunity encourages collaborative investigations combining expertise and is aimed at small businesses with research capabilities and technological expertise relevant to the R&D missions of the NIH, CDC, and FDA awarding components. Applications are not being solicited at this time; the notice is to allow potential applicants time to develop collaborations and responsive projects.